Item Type |
Article |
ID |
|
Preview |
Image |
|
Caption |
|
|
Full text |
KAKEN_16K10699seika.pdf
Type |
:application/pdf |
Download
|
Size |
:89.6 KB
|
Last updated |
:Oct 31, 2019 |
Downloads |
: 3071 |
Total downloads since Oct 31, 2019 : 3071
|
|
Release Date |
|
Title |
Title |
難治組織肺癌である肺多形癌の病態解明・治療開発を目指した分子病理学的研究
|
Kana |
ナンチ ソシキ ハイガン デ アル ハイ タケイガン ノ ビョウタイ カイメイ・チリョウ カイハツ オ メザシタ ブンシ ビョウリガクテキ ケンキュウ
|
Romanization |
Nanchi soshiki haigan de aru hai takeigan no byōtai kaimei chiryō kaihatsu o mezashita bunshi byōrigakuteki kenkyū
|
|
Other Title |
Title |
Pathological and molecular study of lung pleomorphic carcinomas to clarify the pathogenesis and develop novel treatment strategy
|
Kana |
|
Romanization |
|
|
Creator |
Name |
菱田, 智之
|
Kana |
ヒシダ, トモユキ
|
Romanization |
Hishida, Tomoyuki
|
Affiliation |
慶應義塾大学・医学部 (信濃町)・准教授
|
Affiliation (Translated) |
|
Role |
Research team head
|
Link |
科研費研究者番号 : 40544664
|
Name |
栗山, 翔司
|
Kana |
クリヤマ, ショウジ
|
Romanization |
Kuriyama, Shōji
|
Affiliation |
|
Affiliation (Translated) |
|
Role |
Collaborator
|
Link |
|
Name |
中込, 貴博
|
Kana |
ナカゴミ, タカヒロ
|
Romanization |
Nakagomi, Takahiro
|
Affiliation |
|
Affiliation (Translated) |
|
Role |
Collaborator
|
Link |
|
Name |
|
Kana |
|
Romanization |
|
Affiliation |
|
Affiliation (Translated) |
|
Role |
|
Link |
|
|
Edition |
|
Place |
|
Publisher |
|
Date |
Issued (from:yyyy) |
2019
|
Issued (to:yyyy) |
|
Created (yyyy-mm-dd) |
|
Updated (yyyy-mm-dd) |
|
Captured (yyyy-mm-dd) |
|
|
Physical description |
|
Source Title |
Name |
科学研究費補助金研究成果報告書
|
Name (Translated) |
|
Volume |
|
Issue |
|
Year |
2018
|
Month |
|
Start page |
|
End page |
|
|
ISSN |
|
ISBN |
|
DOI |
|
URI |
|
JaLCDOI |
|
NII Article ID |
|
Ichushi ID |
|
Other ID |
|
Doctoral dissertation |
Dissertation Number |
|
Date of granted |
|
Degree name |
|
Degree grantor |
|
|
Abstract |
肺癌の中でも特に高悪性度である、多形癌を含む「肉腫様成分を含む肺癌」を対象とし、新規治療開発を目指した臨床病理学的解析を行なった。23例の検討では、5年無再発生存割合は56%。再発は8例 (35%) に認めたが、7例は術後1年以内の再発で、再発後生存期間中央値は3ヶ月であった。一方、5年無再発生存を6例 (26%) に認めた。「肉腫様成分」を含む肺癌は、過去の報告同様、早期再発を来たし再発後予後も不良である一方で、長期無再発生存例も存在することが示唆された。対象症例はDNA断片化が著明であったため、対象を近年の症例から再抽出し、遺伝子異常、DNAメチル化異常のprofilingを行っている。
We performed clinicopathological and molecular study to clarify pathogenesis of lung cancer with sarcomatous component (LCSC) including pleomorphic carcinoma, which has high-grade malignancy. We reviewed our medical record and identified 23 patients who underwent resection for LCSC from 1996 to 2011. The 5-year recurrence-free survival was 56%, and 8 (35%) patients developed recurrence. Among them, 7 had recurrence within 1 year after surgery, and median post-recurrence survival was only 3 months. On the other hand, 5-year recurrence-free survivors were found in 6 (26%) patients, which suggested that LCSC might have 2 groups in terms of biological behavior; the poor outcome group as shown in previous studies and the favorable outcome group. Next, we conducted molecular analysis to clarify biological signatures in sarcomatous component, a characteristic component associating with malignant behavior of LCSC, comparing with non-sarcomatous component and non-cancerous area of each case.
|
|
Table of contents |
|
Keyword |
|
NDC |
|
Note |
研究種目 : 基盤研究(C)(一般)
研究期間 : 2016~2018
課題番号 : 16K10699
研究分野 : 呼吸器外科学
|
|
Language |
|
Type of resource |
|
Genre |
|
Text version |
|
Related DOI |
|
Access conditions |
|
Last modified date |
|
Creation date |
|
Registerd by |
|
History |
|
Index |
|
Related to |
|